Novartis AG (NVS)
102.10
+1.90
(+1.89%)
USD |
NYSE |
May 10, 16:00
102.59
+0.48
(+0.48%)
After-Hours: 19:23
Novartis Long Term Receivables (Quarterly)
Long Term Receivables (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Long Term Receivables (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
Date | Value |
---|---|
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
December 31, 2020 | -- |
September 30, 2020 | -- |
June 30, 2020 | -- |
March 31, 2020 | -- |
December 31, 2019 | -- |
Long Term Receivables Definition
Long Term Receivables are the debts owed to a company that are due more than twelve months from the last recorded date. In accounting, long term receivables are classified under long-term assets.
Long Term Receivables (Quarterly) Range, Past 5 Years
Long Term Receivables (Quarterly) Benchmarks
Roche Holding AG | -- |
Sandoz Group AG | -- |
Amgen Inc | -- |
Incyte Corp | -- |
MorphoSys AG | -- |